title: Four-year experience with vismodegib hedgehog inhibitor therapy.
authors.affiliation: Internal Medicine Residency Program, Florida Atlantic University College of Medicine, Boca Raton, Florida.
authors.forename: Peter D
authors.initials: PD
authors.lastname: Simone
authors.affiliation: Strasswimmer Mohs Surgery, Delray Beach, Florida.
authors.forename: Jamie M
authors.initials: JM
authors.lastname: Schwarz
authors.affiliation: Departments of Surgery, Internal Medicine, and Biochemistry, Florida Atlantic University, Boca Raton, Florida; Broward Health Dermatology Residency Program, Ft Lauderdale, Florida. Electronic address: strassmail2014@gmail.com.
authors.forename: John M
authors.initials: JM
authors.lastname: Strasswimmer
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000813:Anilides / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; D053823:Hedgehog Proteins; C538724:HhAntag691; D011725:Pyridines